Maha Radhakrishnan

Director, Alto Neuroscience, Inc.

Companies

Candel TherapeuticsBoard member Jun 6, 2025 to now¹
Entrada Therapeutics, Inc.Board member Jun 3, 2025 to now²
Alto Neuroscience, Inc.Board member Mar 12, 2024 to Mar 12, 2024³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCandel Therapeutics, Board member
2
SEC EDGAREntrada Therapeutics, Inc., Board member
3
SEC EDGARAlto Neuroscience, Inc., Board member